Castle Biosciences (CSTL) PT Raised to $44 at BTIG

August 3, 2026 6:10 AM EDT Send to a Friend
BTIG analyst Sung Ji Nam raised the price target on Castle Biosciences (NASDAQ: CSTL) to $44.00 (from $40.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login